RSSCategory: Pharmaceuticals

CEPI urges fast-tracking of vaccines for three potential disease outbreaks

January 20, 2017
CEPI urges fast-tracking of vaccines for three potential disease outbreaks

The Coalition for Epidemic Preparedness Innovations (CEPI), a public-private coalition that aims to derail epidemics by speeding development of vaccines, has committed US$460million to speed up vaccine development for MERS, Lassa fever and Nipah virus – three relatively little-known diseases scientists think could cause the next global health emergency. Aiming to have two new experimental [...]

Continue Reading

US CDC finds superbug resistant to all kinds of antibiotic

January 18, 2017
US CDC finds superbug resistant to all kinds of antibiotic

The US Centers for Disease Control and Prevention (CDC) report has confirmed that a 70-year-old woman from Nevada in the US has died after being infected with a superbug that is “resistant to all available antimicrobial drugs”. The victim broke her right leg during a long stay in India and had repeatedly needed hospital treatment [...]

Continue Reading

Guardant Health partners with top pharma companies to speed clinical trials

January 9, 2017
Guardant Health partners with top pharma companies to speed clinical trials

Guardant Health, an oncology-focused company based in California in the US, is partnering with leading international pharmaceutical companies to create a 500-plus-gene liquid biopsy panel that will help drug companies accelerate clinical trials and the development of targeted cancer drugs and immunotherapies. The company has entered into separate agreements with British-Swedishbio pharmaceutical company AstraZeneca, American [...]

Continue Reading

Novartis invests in potential cardiovascular therapies from Ionis

January 9, 2017
Novartis invests in potential cardiovascular therapies from Ionis

Basel, Switzerland-based multinational pharmaceutical company Novartis International AG has entered into a collaboration and option agreement with Ionis Pharmaceuticals Inc. and its subsidiary Akcea Therapeutics Inc. to license two experimental cardiovascular treatments. The investigational antisense therapies – called AKCEA-APO(a)-LRx and AKCEA-APOCIII-LRx – from the US-based companies have the potential to significantly reduce cardiovascular risk in [...]

Continue Reading

US judge favors Amgen Inc. in patent lawsuit against Sanofi, Regeneron

January 6, 2017
US judge favors Amgen Inc. in patent lawsuit against Sanofi, Regeneron

A federal judge in the state of Delaware in the US has favored California-based multinational biopharmaceutical company Amgen Inc. in a patent infringement lawsuit filed against Sanofi SA and Regeneron Pharmaceuticals, Inc. over a cholesterol drug. U.S. District Judge Sue Robinson in Delaware ordered a ban on the sales of Praluent, a cholesterol drug from [...]

Continue Reading

Quetta, Pakistan launches five-day polio campaign as officials find rare strain

January 4, 2017
Quetta, Pakistan launches five-day polio campaign as officials find rare strain

The southwestern city of Quetta, capital of the Balochistan province in Pakistan, has launched a new five-day polio immunization campaign for children under five years of age after sewage samples were found to contain a rare strain of the virus, according to local officials. Muslim clerics were also recruited by local officials to promote the [...]

Continue Reading

Singapore creates national action plan against antimicrobial resistance

December 28, 2016
Singapore creates national action plan against antimicrobial resistance

As more and more Singaporeans use antibiotics as a quick fix for their ailments, the country’s governmentaims to tackle the growing problem of antimicrobial resistance (AMR) in the country with the development a national action plan. Singapore’s Ministry of Health (MOH) said it is working with the Agri-Food and Veterinary Authority (AVA), the National Environment [...]

Continue Reading

WHO: Successful Ebola vaccine may be available for use by 2018

December 28, 2016
WHO: Successful Ebola vaccine may be available for use by 2018

According to the World Health Organization (WHO), a successful Ebola vaccine that protects against the fatal virus may be available for use by 2018 as it is currently being fast-tracked for regulatory approval. Trials conducted in Guinea, one of the West African countries most affected by an outbreak of Ebola that ended this year, show [...]

Continue Reading

“Landmark” drug is first to work in primary progressive multiple sclerosis

December 23, 2016
“Landmark” drug is first to work in primary progressive multiple sclerosis

A “landmark” drug that alters the human immune system to treat multiple sclerosis (MS) has been found to be the first drug shown to work in the primary progressive form of the disease in trials. The drug, called ocrelizumab, is being reviewed for use in the US and Europe. MS is caused by a rogue [...]

Continue Reading

Allergan to acquire Acelity’s LifeCell for US$2.9 bn

December 21, 2016
Allergan to acquire Acelity’s LifeCell for US$2.9 bn

Global pharmaceutical company Allergan Plc has announced its plans to acquire Acelity LP Inc.’s regenerative medicine unit Life Cell in a US$2.9 billion deal that will expand Allergan’s portfolio of medical aesthetics, breast implants and tissue expanders, the company said. LifeCell makes regenerative tissue products that are commonly used in breast reconstruction procedures and complex [...]

Continue Reading